<?xml version="1.0" encoding="UTF-8"?>
<p>NF-κB has been considered as an attractive therapeutic target for the cancer research. Compound 
 <bold>288</bold> was investigated for its effects on NF-κB pathway by reporter gene assay. The results showed that it could activate the NF-κB pathway with increments in the relative luciferase activity at a concentration of 50 μM [
 <xref rid="B93-ijms-22-00959" ref-type="bibr">93</xref>].
</p>
